People with Alzheimer’s who have low levels of a substance called homocysteine in their blood might respond better to omega-3 supplements than others, and their B vitamin levels could be why.

We analyzed the available evidence and found that 55.0 assertions support the idea that people with Alzheimer’s who have low homocysteine levels in their blood may respond more noticeably to omega-3 supplements than those with higher levels. No assertions in our review contradicted this. The evidence suggests this difference might be linked to levels of B vitamins, which help regulate homocysteine, but we did not find direct proof of how or why this connection exists [1]. Homocysteine is a substance in the blood that, when too high, has been tied to brain health concerns. Some studies suggest that when it’s low, the body might use omega-3 fatty acids more effectively to support brain function in people with Alzheimer’s. The role of B vitamins here is mentioned as a possible factor, since they help break down homocysteine, but we did not see data showing whether taking B vitamins changes the outcome. What we’ve found so far leans toward the idea that homocysteine levels could influence how well omega-3 supplements work for some Alzheimer’s patients. But we also note that this is based on assertions, not controlled studies comparing groups directly. There’s no clear picture yet of how big the effect is, who it applies to, or whether testing homocysteine levels before starting omega-3s makes a practical difference. The evidence we’ve reviewed doesn’t prove this relationship, but it does point to a pattern worth exploring further. For now, if someone with Alzheimer’s is considering omega-3 supplements, checking homocysteine and B vitamin levels might help understand how their body could respond — but it’s not a guarantee of better results.